FDBusiness.com

Nestlé Takes Stake in US Biopharmaceutical Company

 Breaking News
  • Orkla Sells K-Salat to Stryhns Orkla Foods Danmark has agreed to sell its K-Salat business to Stryhns, which is part of the Norwegian Agra group. The purpose of the sale is to concentrate Orkla’s activities on fewer categories. K-Salat has a product portfolio of salad spreads, mayonnaise, remoulade, dressings and potato salads in Denmark. Under the agreement, Stryhns will take over [...]...
  • Ardgowan Secures £1 Million to Build Malt Whisky Distillery and Visitor Centre A project to build a new lowland Scotch malt whisky distillery and visitor centre in Inverclyde has taken major step forward with the award of nearly £1 million from the Scottish Government. The Ardgowan Distillery secured £982,000 from the government’s Food Processing, Marketing and Co-operation (FPMC) grant scheme – providing vital capital towards construction costs. Martin [...]...
  • Irish Craft Beer Sustaining Growth A new Bord Bia report has revealed that Irish craft beer is performing well across all fronts, from the number of production facilities to production output, market share and exports. The number of craft breweries in Ireland has grown by more than 500% in the last 5 years, with 72 now in operation, up from [...]...
  • Fi Europe Innovation Awards – The Shortlisted Companies One of the highlights at Fi Europe & Ni is the announcement of the winners of the Innovation Awards. The competition not only rewards the most innovative products and concepts, it also acts as a reliable trend barometer. The ten-member jury, chaired by Peter Wennström of The Healthy Marketing Team, presents a shortlist of the [...]...
  • Advetec Targets Food and Drink Manufacturers With Next Generation Organic Waste Digester To reduce food processors costs, Advetec, a leading specialist in the treatment and reduction of solid and liquid organic waste, has launched the Advetec XO, an evolution of the company’s successful Bio-Thermic Digester (BTD) technology. The system is designed to rapidly reduce organic content within waste at source,cutting off-site transportation and processing costs and helping food manufacturing companies [...]...

Nestlé Takes Stake in US Biopharmaceutical Company

Nestlé Takes Stake in US Biopharmaceutical Company
November 04
14:32 2016

Nestlé Health Science is to invest $145 million for a 15% stake in US-based Aimmune Therapeutics, a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The parties also entered into a strategic collaboration to accelerate the development of innovative oral immunotherapy biologics designed to desensitize people with food allergies and protect them from the consequences of accidental exposure.

Up to 250 million people globally are estimated to suffer from food allergies, between 5-8% of children and 1-2% of adults. Amongst the top eight food allergies, peanut allergy – generally a lifelong condition – is estimated to impact 6 million people in the US and in Europe or between 0.6 and 1.3% of the population in the US.

Aimmune’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach to treating life-threatening food allergies is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. It aims to provide a transformative treatment option that goes beyond the current standard of care of diligent avoidance of food allergens and carrying epinephrine for administration in case of accidental exposure.

NestleHealthScienceLicenseAgreementAimmune’s lead CODIT product candidate, AR101 for peanut allergy, is a characterized, regulated, oral biological drug product containing the protein profile found in peanuts designed to desensitize patients with peanut allergy. The ongoing Phase III trial, conducted by Aimmune, is expected to deliver results in 4Q2017, which – if positive – may support the filing of marketing authorization in the US and Europe. Per the terms of this collaboration agreement, Aimmune retains the rights to AR101 and all other pipeline assets developed with the CODIT approach.

The investment extends Nestlé Health Science’s interests in the food allergy arena. Nestlé Health Science already has an established portfolio of nutritional solutions for pediatric food allergy and intolerances, especially Cow’s Milk Protein Allergy (CMPA), as well as a simple, fast and easy-to-use awareness tool – CoMiSS® (Cow’s Milk-related Symptom Score) – which enables primary healthcare professionals to earlier recognize and assess symptoms that may be related to CMPA in infants. Earlier this year the company partnered with DBV Technologies on the development of a skin-patch test tool for the improved diagnosis of CMPA.

Greg Behar, chief executive of Nestlé Health Science, who will take a seat on the Aimmune Board, comments: “Food allergies have a huge personal impact and are a health economic burden. We are investing and innovating to change the approach to food allergy management with integrated approaches from diagnostics (Dx), to nutrition solutions (Nx) and now biologics (Rx), where Aimmune’s proprietary approach has transformational potential in lives of patients and families.”

The strategic investment launches a two-year strategic collaboration between Nestlé Health Science and Aimmune, the terms of which enable the parties to engage on Aimmune’s current and future oral immunotherapy development programs through a newly established pipeline forum. Nestlé Health Science will provide ongoing scientific, regulatory and commercial expertise and advice to Aimmune through the pipeline forum and in addition has a three-month exclusive right of first negotiation for any development program in the event Aimmune considers licensing or partnering such a program.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • November 28, 2017Fi Europe
  • December 4, 2017Plastics and Paper in Contact with Foodstuffs 2017
  • January 8, 2018RAI Exhibition
  • January 16, 2018Sival Plant Production Trade Show
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements